{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:06:17Z","timestamp":1753891577910,"version":"3.41.2"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T00:00:00Z","timestamp":1721347200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Osteoarthritis (OA) and calcium pyrophosphate deposition (CPPD) often co-exist, this resulting in a clinical condition characterized by amplified inflammation and more severe and faster cartilage degeneration compared to OA alone. Our study aims to explore the efficacy of a therapeutic approach that addresses both conditions, using a combination of a high molecular weight hyaluronic acid (HMWHA) and collagen tripeptide (CTP). Additionally, safety profile and baseline characteristic predictive value were evaluated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We conducted a retrospective study on patients diagnosed with symptomatic knee OA (KOA) and CPPD treated by ultrasound (US) guided intraarticular injections of HMWHA-CT in the outpatient clinics of the Interdisciplinary Pain Medicine Unit at Santa Maria Maddalena Hospital, Occhiobello, Italy and in the Rheumatology Unit of the Emergency County Hospital Craiova, Romania (ECH Craiova). All the patients underwent clinical and US evaluation at baseline, 1, 3, and 6 months. From clinical point of view, Numeric Rating Scale (NRS) pain and Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) were recorded. US data included detection of synovitis, cartilage damage, osteophytes, and CPPD deposits. Clinical efficacy was defined with NRS and WOMAC variations in respect to baseline and using the minimal clinically important difference values: an improvement of 2 point for NRS pain and 10 for the total score for WOMAC.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Twenty-nine patients (34 knees) were injected and evaluated. Overall pain levels, as measured by NRS, demonstrated a consistent decrease in patients across all follow-up intervals, with the most substantial improvement at the 6-month compared to baseline measurements. A significative proportion of patients achieved the minimum clinically detectable improvement, specifically 79% for NRS and 83% for WOMAC (19 and 20 patients, respectively).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Our data showed a significant efficacy of ultrasound guided HMWHA-CT, in patients with KOA and CPPD, thus making it reasonable to consider that the combination of HMWHA and CTP can provide a strong anti-inflammatory effect.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2024.1437160","type":"journal-article","created":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T04:56:14Z","timestamp":1721364974000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy of a single ultrasound-guided injection of high molecular weight hyaluronic acid combined with collagen tripeptide in patients with knee osteoarthritis and chondrocalcinosis"],"prefix":"10.3389","volume":"11","author":[{"given":"Francesco","family":"Porta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilio","family":"Filippucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edoardo","family":"Cipolletta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"La Grua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xenia","family":"Barni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Sirotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florentin Ananu","family":"Vreju","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,7,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1016\/j.joca.2011.08.009h","article-title":"The effect of osteoarthritis definition on prevalence and incidence estimates: A systematic review.","volume":"19","author":"Pereira","year":"2011","journal-title":"Osteoarthritis Cartilage."},{"key":"B2","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.joca.2014.01.003","article-title":"OARSI guidelines for the non-surgical management of knee osteoarthritis.","volume":"22","author":"McAlindon","year":"2014","journal-title":"Osteoarthritis Cartilage."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1327715","article-title":"Recent advances in the therapeutic management of calcium pyrophosphate deposition disease.","volume":"11","author":"Voulgari","year":"2024","journal-title":"Front Med."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2021.101720","article-title":"Calcium pyrophosphate deposition (CPPD) disease \u2013 Treatment options.","volume":"35","author":"Stack","year":"2021","journal-title":"Best Pract Res Clin Rheumatol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1093\/rheumatology\/kead228","article-title":"Retention, safety and efficacy of off-label conventional treatments and biologics for chronic calcium pyrophosphate crystal inflammatory arthritis.","volume":"63","author":"Damart","year":"2024","journal-title":"Rheumatology."},{"key":"B6","doi-asserted-by":"publisher","first-page":"15","DOI":"10.5152\/eurjrheum.2023.21093","article-title":"Chondrocalcinosis and osteoarthritis: A literature review.","volume":"11","author":"Guo","year":"2024","journal-title":"Eur J Rheumatol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.joca.2019.10.003","article-title":"Chondrocalcinosis is associated with increased knee joint degeneration over 4 years: Data from the osteoarthritis initiative.","volume":"28","author":"Foreman","year":"2020","journal-title":"Osteoarthritis Cartilage."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1007\/s00330-016-4608-8","article-title":"Evaluation of chondrocalcinosis and associated knee joint degeneration using MR imaging: Data from the osteoarthritis initiative.","volume":"27","author":"Gersing","year":"2017","journal-title":"Eur Radiol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s10067-023-06805-3","article-title":"Ultrasound reveals a high prevalence of CPPD in consecutive patients with knee pain.","volume":"43","author":"Cipolletta","year":"2024","journal-title":"Clin Rheumatol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1136\/ard.42.3.280","article-title":"Osteoarthritis and articular chondrocalcinosis in the elderly.","volume":"42","author":"Wilkins","year":"1983","journal-title":"Ann Rheum Dis."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1002\/acr.23204","article-title":"Use of intraarticular hyaluronic acid in the management of knee osteoarthritis in clinical practice.","volume":"69","author":"Cooper","year":"2017","journal-title":"Arthritis Care Res."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1186\/s12891-020-03577-8","article-title":"Efficacy of single high-molecular-weight versus triple low-molecular-weight hyaluronic acid intra-articular injection among knee osteoarthritis patients.","volume":"21","author":"Bahrami","year":"2020","journal-title":"BMC Musculoskelet Disord."},{"key":"B13","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1111\/j.1365-2362.2009.02144.x","article-title":"Effect of polymerized-type I collagen in knee osteoarthritis. II. In vivo study.","volume":"39","author":"Furuzawa-Carballeda","year":"2009","journal-title":"Eur J Clin Invest."},{"key":"B14","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1111\/j.1365-2362.2009.02154.x","article-title":"Effect of polymerized-type I collagen in knee osteoarthritis. I. In vitro study.","volume":"39","author":"Furuzawa-Carballeda","year":"2009","journal-title":"Eur J Clin Invest."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1100\/2012\/342854","article-title":"Polymerized-type I collagen downregulates inflammation and improves clinical outcomes in patients with symptomatic knee osteoarthritis following arthroscopic lavage: A randomized, double-blind, and placebo-controlled clinical trial.","volume":"2012","author":"Furuzawa-Carballeda","year":"2012","journal-title":"ScientificWorldJournal."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1186\/ar4181","article-title":"Periodic knee injections of collagen tripeptide delay cartilage degeneration in rabbit experimental osteoarthritis.","volume":"15","author":"Naraoka","year":"2013","journal-title":"Arthritis Res Ther."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.mser.2021.100641","article-title":"Collagen- and hyaluronic acid-based hydrogels and their biomedical applications.","volume":"146","author":"Xu","year":"2021","journal-title":"Mater Sci Eng R Rep."},{"key":"B18","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1136\/ard.2010.139105","article-title":"European league against rheumatism recommendations for calcium pyrophosphate deposition. Part I: Terminology and diagnosis.","volume":"70","author":"Zhang","year":"2011","journal-title":"Ann Rheum Dis."},{"key":"B19","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1002\/art.42368","article-title":"Reliability and diagnostic accuracy of radiography for the diagnosis of calcium pyrophosphate deposition: Performance of the novel definitions developed by an international multidisciplinary working group.","volume":"75","author":"Sirotti","year":"2023","journal-title":"Arthritis Rheumatol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.3899\/jrheum.161057","article-title":"Definition and reliability assessment of elementary ultrasonographic findings in calcium pyrophosphate deposition disease: A study by the OMERACT calcium pyrophosphate deposition disease ultrasound subtask force.","volume":"44","author":"Filippou","year":"2017","journal-title":"J Rheumatol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.3899\/jrheum.181095","article-title":"OMERACT definitions for ultrasonographic pathologies and elementary lesions of rheumatic disorders 15 years on.","volume":"46","author":"Bruyn","year":"2019","journal-title":"J Rheumatol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1136\/annrheumdis-2014-206774","article-title":"An OMERACT reliability exercise of inflammatory and structural abnormalities in patients with knee osteoarthritis using ultrasound assessment.","volume":"75","author":"Bruyn","year":"2016","journal-title":"Ann Rheum Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1136\/annrheumdis-2017-211585","article-title":"The 2017 EULAR standardised procedures for ultrasound imaging in rheumatology.","volume":"76","author":"M\u00f6ller","year":"2017","journal-title":"Ann Rheum Dis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1002\/acr.21574","article-title":"Development and evaluation of a novel ultrasound score for large joints in rheumatoid arthritis: One year of experience in daily clinical practice.","volume":"64","author":"Hartung","year":"2012","journal-title":"Arthritis Care Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1136\/annrheumdis-2017-212542","article-title":"Identification of calcium pyrophosphate deposition disease (CPPD) by ultrasound: Reliability of the OMERACT definitions in an extended set of joints - An international multiobserver study by the OMERACT calcium pyrophosphate deposition disease ultrasound subtask force.","volume":"77","author":"Filippou","year":"2018","journal-title":"Ann Rheum Dis."},{"key":"B26","doi-asserted-by":"publisher","first-page":"17","DOI":"10.5704\/MOJ.1507.013","article-title":"Meniscal extrusion in the knee: Should only 3 mm extrusion be considered significant? An assessment by MRI and arthroscopy.","volume":"9","author":"Muzaffar","year":"2015","journal-title":"Malays Orthop J."},{"key":"B27","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1097\/RUQ.0000000000000288","article-title":"In-plane ultrasound-guided knee injection through a lateral suprapatellar approach: A safe technique.","volume":"33","author":"Chagas-Neto","year":"2017","journal-title":"Ultrasound Q."},{"key":"B28","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1111\/j.1365-2702.2005.01121.x","article-title":"Pain: A review of three commonly used pain rating scales.","volume":"14","author":"Williamson","year":"2005","journal-title":"J Clin Nurs."},{"key":"B29","doi-asserted-by":"publisher","first-page":"615","DOI":"10.3899\/jrheum.210543","article-title":"WOMAC meaningful within-patient change: Results from 3 studies of tanezumab in patients with moderate-to-severe osteoarthritis of the hip or knee.","volume":"49","author":"Conaghan","year":"2022","journal-title":"J Rheumatol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.ejpain.2003.09.004","article-title":"Minimal clinically important changes in chronic musculoskeletal pain intensity measured on a numerical rating scale.","volume":"8","author":"Salaffi","year":"2004","journal-title":"Eur J Pain."},{"key":"B31","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1097\/CORR.0000000000000444","article-title":"What is the minimum clinically important difference for the WOMAC index after TKA?","volume":"476","author":"Clement","year":"2018","journal-title":"Clin Orthop."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1177\/1179544117723611","article-title":"The disease-modifying effects of hyaluronan in the osteoarthritic disease state.","volume":"10","author":"Nicholls","year":"2017","journal-title":"Clin Med Insights Arthritis Musculoskelet Disord."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2021.101722","article-title":"The role of calcium crystals and their effect on osteoarthritis pathogenesis.","volume":"35","author":"St\u00fccker","year":"2021","journal-title":"Best Pract Res Clin Rheumatol."},{"key":"B34","doi-asserted-by":"crossref","first-page":"66","DOI":"10.55563\/clinexprheumatol\/gu9j0q","article-title":"The two faces of the same medal\u2026or maybe not? Comparing osteoarthritis and calcium pyrophosphate deposition disease: A laboratory and ultrasonographic study.","volume":"7","author":"Filippou","year":"2021","journal-title":"Clin Exp Rheumatol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1002\/1529-0131(199805)41:53.0.CO;2-D","article-title":"Pseudogout following intraarticular injection of sodium hyaluronate.","volume":"41","author":"Luzar","year":"1998","journal-title":"Arthritis Rheum."},{"key":"B36","first-page":"593","article-title":"Acute attack of chondrocalcinosis after an intraarticular injection of hyaluronan.","volume":"64","author":"Maillefert","year":"1997","journal-title":"Rev Rhum Engl Ed."},{"key":"B37","first-page":"169","article-title":"Synovial inflammation in patients with different stages of knee osteoarthritis.","volume":"56","author":"Ene","year":"2015","journal-title":"Rom J Morphol Embryol."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1437160\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T04:56:17Z","timestamp":1721364977000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1437160\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,19]]},"references-count":37,"alternative-id":["10.3389\/fmed.2024.1437160"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2024.1437160","relation":{},"ISSN":["2296-858X"],"issn-type":[{"type":"electronic","value":"2296-858X"}],"subject":[],"published":{"date-parts":[[2024,7,19]]},"article-number":"1437160"}}